Embargo: 3 p.m. MT/ 5 p.m. ET, Thursday, March 3, 2016, Abstract 392
Check. Change. Control ™ blood pressure reduction program works to lower seniors’ BP
The American Heart Association’s Check. Change. Control ™ blood pressure reduction program helped Asian and Hispanic older adults make notable reductions in their blood pressure, according to a study presented at the American Heart Association’s Epidemiology/Lifestyle 2016 Scientific Sessions.
In this study, researchers studied the program’s effectiveness in a group of 122 Chinese and Hispanic adults older than 62 years of age. Participants learned how to self-monitor and track their blood pressure, using the Heart360 digital tool.
At the study’s start, nearly 47 percent of participants had elevated blood pressure (defined as140/90 mm Hg or higher). At the end of the study four months later, 41 percent had high blood pressure, an improvement of nearly 6 percent.
More than 36 percent of those in the study had a systolic blood pressure drop of more than 10 mm Hg from the start to the end of the four-month study.
The American Heart Association is rolling out its Check. Change. Control ™ program across the United States to help people manage their blood pressures through local health mentors. This research contributes to a better understanding of the patient factors that best predict blood pressure reduction, according to the authors.
Note: Actual presentation time of Abstract 392 is 5 p.m. MT/7 p.m.ET, Thursday, March 3, 2016.
Rohini Patel, University of California, Irvine, San Diego, California.
- Photos available on the right column of this release link http://newsroom.heart.org/news/thursday-news-tip?preview=bb56b7f9d64f7a704baf49096a3d810c
- Follow AHA/ASA news on Twitter @HeartNews
Statements and conclusions of study authors that are presented at American Heart Association scientific meetings are solely those of the study authors and do not necessarily reflect association policy or position. The association makes no representation or warranty as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at www.heart.org/corporatefunding.
For media inquiries about this news release and AHA spokesperson perspective:
Darcy Spitz: (212) 878-5940; email@example.com
Julie Del Barto (national broadcast): (214) 706-1330; firstname.lastname@example.org
For general media inquiries:
American Heart Association Communications: (214) 706-1173
For Public Inquiries:
Life is why, science is how . . . we help people live longer, healthier lives.